Cayenne Medical was founded in March 2005 as a multidisciplinary sports medicine company to address unmet clinical needs in arthroscopic surgery.
To become the leader in the soft tissue reconstruction and repair segment of the orthopedic sports medicine market by expanding the range of treatments that drive medical advancements.
Develop simple, yet comprehensive approaches to enable the vast majority of orthopedic surgeons to perform various soft tissue repairs and to enhance patient outcomes.
Advancements in arthroscopic surgery have expanded the range of possible treatments for joint injuries and have driven the emergence of sports medicine. Arthroscopic surgery enables surgeons to perform minimally invasive surgery on delicate joints such as the knee, shoulder, ankle and elbow.
Cayenne has captured this market momentum and developed a revolutionary platform technology that answers all current unmet needs in soft tissue ACL reconstruction. The AperFix® System represents a quantum leap over competitive approaches in the knee market. AperFix facilitates unparalleled anatomic reconstruction via a simplified single tunnel, double bundle technique. It is a highly effective solution for ACL reconstruction that will enable widespread, rapid adoption of the procedure among orthopedic surgeons.
Expansion of Cayenne’s core technology beliefs, lead to the development of the iFix™ Interference Screw System for bone-patellar tendon-bone reconstructions. Once again unmet needs have been answered for this ACL reconstruction technique, combining strength of repair and biocompatibility with ease of use and reduced surgical time.
As the company moves forward with additional product offerings three distinct advantages will continue to be its core:
The combination of a focused marketing approach, innovative technology and a strong management team will allow Cayenne Medical to emerge as the leader in the knee segment of the sports medicine market.
Cayenne has received 510(k) market clearance from the US Food and Drug Administration for the AperFix® System, iFix™ System and CrossFix™ System and all the products are available for clinical use in the United States. Additionally Cayenne holds a CE Mark for the design and manufacture of femoral and tibial implants with inserters, interference screws and instruments for tissue reconstruction. Cayenne operates a Quality Management system, which complies with the requirements of ISO 13485:2003.